WOBURN, Mass., Feb. 28, 2018 -- Yield10 Bioscience,Inc. (NASDAQ:YTEN) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference call with management after market close on Thursday, March 8, 2018.
Shareholders will participate in the call in listen-only mode. The Company invites shareholders to submit questions for consideration by March 5, 2018 to [email protected] with the subject line: “Questions for Year-end Call.” Questions submitted in advance of the call will be reviewed and some will be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Thursday, March 8 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com. The webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial 877-660-6853 (toll-free) or 201-612-7415 (international) and enter passcode 13676737. The replay will be available for 14 days.
About Yield10
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and rice. Yield10 is headquartered in Woburn, MA and has an Oilseeds center of excellence in Saskatoon, Canada.
For more information about the Company, please visit www.yield10bio.com. (YTEN-E)
Yield10 Inquiries:
Lynne H. Brum, (617) 682-4693, [email protected]
Investor Relations Contact:
Amato and Partners, LLC
90 Park Avenue, 17th Floor
New York, NY 10016
[email protected]


Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
OpenAI Restricts Astra AI Over Cyberattack Risks
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 



